Epicore Biosystems Secures $26M in Series B Funding to Revolutionize Sweat-Sensing Wearables for Health Insights

Epicore Biosystems is excited to announce a significant milestone in its journey of innovation and growth with a successful funding round of $26,000,000.

This impressive capital injection will further accelerate our mission to revolutionize the digital health landscape.

As a pioneer in creating advanced sweat-sensing wearables, Epicore Biosystems delivers real-time, personalized health insights that empower individuals to understand and manage their hydration, stress, and overall wellness.

Our clinically validated products have already made their mark on a global scale, being trusted and licensed by leading brands across the sports and fitness, occupational safety, and clinical trial sectors.

With this new funding, we plan to expand our research and development efforts, enabling us to refine our wearable technologies and explore new avenues that push the boundaries of what digital health can achieve.

Additionally, the funds will support the scaling of our manufacturing processes to meet growing demand and allow us to penetrate untapped markets around the world.

By investing in our innovative platform and technology, stakeholders are not only fueling our growth but also supporting a future where real-time health monitoring becomes an integral part of daily life.

This investment reinforces our commitment to enhancing individual wellness through accurate, data-driven insights tailored to each user’s unique needs.

We are proud to be at the forefront of digital health innovation, and this funding milestone marks a pivotal step toward expanding our impact and continuing our mission to empower healthier lives globally.